Cellular therapies for liver replacement

Transplant Immunology

Volumn 12, Issue 3-4, 2004, Pages 273-288

  Selden, Clare ^a   Hodgson, Humphrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bioartificial liver; Cell transplantation; Hepatocyte transplantation

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; CELL CULTURE; CELL DISRUPTION; CELL ENCAPSULATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CRYOPRESERVATION; DERIVATIZATION; EXPERIMENTAL TEST; GENE CONTROL; GENETIC MARKER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KUPFFER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; OUTCOMES RESEARCH; OXYGENATION; PRIORITY JOURNAL; REVIEW; SERTOLI CELL; STEM CELL TRANSPLANTATION; TECHNIQUE; TISSUE ENGINEERING; XENOGRAFT;

EID: 2442421067     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2003.12.008     Document Type: Article

References (113)

1. Higgins G.M., Anderson R.M. Experimental pathology of liver; restoration of liver of white rat following partial surgical removal. Arch Pathol. 12:1931;186-202
2. Fausto N. Liver regeneration. J Hepatol. 32:(1 Suppl):2000;19-31
3. Diehl A.M. Liver regeneration. Front Biosci. 7:7 January 2002;e301-e314
4. Zimmermann A. Liver regeneration: the emergence of new pathways. Med Sci Monit. 8:(3):2002;RA53-RA63
5. Mito M., Ebata H., Kusano M., Onishi T., Hiratsuka M., Saito T. Studies on ectopic liver utilizing hepatocyte transplantation into the rat spleen. Transplant P. 11:1979;585-591
6. Darby H., Gupta S., Johnstone R., Selden C., Hodgson H.J. Observations on rat spleen reticulum during the development of syngeneic hepatocellular implants. Br J Exp Pathol. 67:(3):1986;329-339
7. Selden A.C., Darby H., Hodgson H. Further observations on the survival, proliferation and function of ectopically implanted syngeneic and allogeneic liver cells in rat spleen. Eur J Hepat Gastroen. 3:1991;607-611
8. Gupta S., Johnstone R., Darby H., Selden C., Price Y., Hodgson H.J. Transplanted isolated hepatocytes: effect of partial hepatectomy on proliferation of long-term syngeneic implants in rat spleen. Pathology. 19:(1):1987;28-30
9. Selden C., Calnan D., Morgan N., Wilcox H., Carr E., Hodgson H.J. Histidinemia in mice: a metabolic defect treated using a novel approach to hepatocellular transplantation. Hepatology. 21:(5):1995;1405-1412
10. Gupta S., Chowdhury N.R., Jagtiani R., Gustin K., Aragona E., Shafritz D.A., et al. A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation. 50:1990;472-475
11. Gupta S., Rajvanshi P., Malhi H., Slehria S., Sokhi R.P., Vasa S.R., et al. Cell transplantation causes loss of gap junctions and activates GGT expression permanently in host liver. Am J Physiol Gastrointest Liver Physiol. 279:(4):2000;G815-G826
12. Slehria S., Rajvanshi P., Ito Y., Sokhi R.P., Bhargava K.K., Palestro C.J., et al. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology. 35:(6):2002;1320-1328
13. Gupta S., Rajvanshi P., Sokhi R., Slehria S., Yam A., Ken- A., et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology. 29:(2):1999;509-519
14. Joseph B., Malhi H., Bhargava K.K., Palestro C.J., McCuskey R.S., Gupta S. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology. 123:(5):2002;1677-1685
15. Overturf K., Al Dhalimy M., Tanguay R., Brantly M., Ou C.N., Finegold M., et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet. 12:(3):1996;266-273. [see comments] [published erratum appears in Nat Genet 1996 Apr;12(4):458]
16. Muraca M., Gerunda G., Neri D., Vilei M.T., Granato A., Feltracco P., et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet. 359:(9303):26 January 2002;317-318
17. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., Strom S.C., et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics. 111:(6 Pt 1):2003;1262-1267
18. Dhawan A., Mitry R.R., Hughes R.D., Lehec S., Terry C., Champion M., et al. Hepatocyte transplanation in children with liver-based metabolic disorders. BASL. 16:2003;2003
19. Sokal E.M., Smets F., Bourgois A., Van Maldergem L., Buts J.P., Reding R., et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation. 76:(4):27 August 2003;735-738
20. Wang L.J., Chen Y.M., George D., Smets F., Sokal E.M., Bremer E.G., et al. Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences. Liver Transplant. 8:(9):2002;822-828
21. Funkhouser A.W., Vahed S., Soriano H.E. A 'real time' PCR assay to detect transplanted human liver cells in RAG-1/mice. Cell Transplant. 10:(1):2001;91-99
22. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. New Engl J Med. 338:(20):14 May 1998;1422-1426
23. Mitry R.R., Hughes R.D., Aw M.M., Terry C., Mieli-Vergani G., Girlanda R., et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 12:(1):2003;69-74
24. Mitry R.R., Hughes R.D., Dhawan A. Progress in human hepatocytes: isolation, culture and cryopreservation. Semin Cell Dev Biol. 13:(6):2002;463-467
25. Soriano H. Liver cell transplantation: human applications in adults and children. Gupta S., Jansen P.L., Klempnauer J., Manns M.P. Falk Symposium 126 Hepatocyte Transplantation. 10:2002;99-115 Kluwer Academic Publishers, Dordrecht, Boston, London
26. Strom S.C., Fisher R.A., Thompson M.T., Sanyal A.J., Cole P.E., Ham J.M., et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 63:(4):27 February 1997;559-569
27. Bilir B.M., Guinette D., Karrer F., Kumpe D.A., Krysl J., Stephens J., et al. Hepatocyte transplantation in acute liver failure. Liver Transplant. 6:(1):2000;32-40
28. Habibullah C.M., Syed I.H., Qamar A., Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 58:(8):27 October 1994;951-952
29. Hammer C. Xenotransplantation for liver therapy or: can porcine hepatocytes generate physiological functions sufficient for a human patient in ALF? Int J Artif Organs. 25:(10):2002;1019-1028
30. Kearns-Jonker M., Swensson J., Ghiuzeli C., Chu W., Osame Y., Starnes V., et al. The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitors. J Immunol. 163:(8):15 October 1999;4399-4412
31. Sakai Y., Naruse K., Nagashima I., Muto T., Suzuki M. In vitro function of porcine hepatocyte spheroids in 100% human plasma. Cell Transplant. 5:(5 Suppl 1):1996;S41-S43
32. Callery M.P., Mangino M.J., Flye M.W. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells - a basis of portal venous tolerance. Transplantation. 51:(5):1991;1076-1080
33. Wong H., Chang T.M. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomater Artif Cells Artif Organs. 16:(4):1988;731-739
34. Lanza R.P., Jackson R., Sullivan A., Ringeling J., McGrath C., Kühtreiber W., et al. Xenotransplantation of cells using biodegradable microcapsules. Transplantation. 67:(8):1999;1105-1111
35. Furutani M., Arii S., Monden K., Adachi Y., Funaki N., Higashitsuji H., et al. Immunologic activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury. J Lab Clin Med. 123:(3):1994;430-436
36. Takebe K., Shimura T., Munkhbat B., Hagihara M., Nakanishi H., Tsuji K. Xenogeneic (pig to rat) fetal liver fragment transplantation using macrocapsules for immunoisolation. Cell Transplant. 5:(5 Suppl 1):1996;S31-S33
37. Gomez N., Balladur P., Calmus Y., Baudrimont M., Honiger J., Delelo R., et al. Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats. Transplantation. 63:(12):1997;1718-1723
38. Sarkis R., Wen L., Honiger J., Baudrimont M., Delelo R., Calmus Y., et al. Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver. Chirurgie. 123:(1):1998;41-46
39. Liu X., Chism J.P., LeCluyse E.L., Brouwer K.R., Brouwer K.L. Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos. 27:(6):1999;637-644
40. Korbutt G.S., Ao Z., Flashner M., Elliott J.F., Rajotte R.V. Coencapsulation of allogeneic islets with allogeneic Sertoli cells prolongs graft survival without systemic immunosuppression. Transplant P. 30:(2):1998;419
41. Yang H., Wright J.R. Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation. 67:(6):27 March 1999;815-820
42. Tee L.B., Kirilak Y., Huang W.H., Morgan R.H., Yeoh G.C. Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. Carcinogenesis. 15:(12):1994;2747-2756
43. Selawry H.P., Cameron D.F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 2:(2):1993;123-129
44. Deitch E.A., Xu D., Franko L., Ayala A., Chaudry I.H. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1:(2):1994;141-145
45. Sanberg P.R., Saporta S., Borlongan C.V., Othberg A.I., Allen R.C., Cameron D.F. The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant. 6:(2):1997;191-193
46. Koji T., Hishikawa Y., Ando H., Nakanishi Y., Kobayashi N. Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis. Biol Reprod. 64:(3):2001;946-954
47. George J., Roulot D., Koteliansky V.E., Bissell D.M. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Nati Acad Sci USA. 96:(22):26 October 1999;12 719-12 724
48. Suarez-Pinzon W., Korbutt G.S., Power R., Hooton J., Rajotte R.V., Rabinovitch A. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta 1-dependent mechanism. Diabetes. 49:(11):2000;1810-1818
49. Hughes R.D., Williams R. Use of sorbent columns and haemofiltration in fulminant hepatic failure. Blood Purif. 11:(3):1993;163-169
50. Sen S., Mookerjee R.P., Davies N.A., Williams R., Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharm Therap. 16:(Suppl 5):2002;32-38
51. Sussman N.L., Kelly J.H. Extracorporeal liver support; cell-based therapy for the failing liver. Am J Kidney Dis. 30:(5 Suppl 4):1997;S66-S71
52. Smalley M, Selden C, O'Hare M, Hodgson HJF. Cell lines derived from normal human liver by infection with a retrovirus containing the SV40 large T antigen. Gut38sl, A57, 1996
53. Smalley M.J., McCloskey P., Leiper K., O'Hare M.J., Hodgson H.J.F. Cell strains derived from normal human hepatocytes by infection with a retrovirus containing the SV40 large-T-antigen. Hepatology. 24:(4):1996;261A
54. Werner A., Duvar S., Müthing J., Büntemeyer H., Kahmann U., Lünsdorf H., et al. Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system. Ann NY Acad Sci. 875:1999;364-368
55. Werner A., Duvar S., Muthing J., Buntemeyer H., Lunsdorf H., Strauss M., et al. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng. 68:(1):2000;59-70
56. Park J., Lee H.-S., Park J.B., Kim C.Y. Establishment of continuous human fetal hepatocyte line by transfection of simian virus 40 T gene. Mol Cells. 6:1996;534-540
57. Yoon J.H., Lee H.V., Lee J.S., Park J.B., Kim C.Y. Development of a non-transformed human liver cell line with differentiated-hepatocyte and urea-synthetic functions: applicable for bioartificial liver. Int J Artif Organs. 22:(11):1999;769-777
58. Kobayashi N., Noguchi H., Westerman K.A., Watanabe T., Matsumura T., Totsugawa T., et al. Successful retroviral gene transfer of simian virus 40 T antigen and herpes simplex virus-thymidine kinase into human hepatocytes. Cell Transplant. 10:(4-5):2001;377-381
59. Kunieda T., Kobayashi N., Sakaguchi M., Okitsu T., Totsugawa T., Watanabe T., et al. Transduction of immortalized human hepatocytes with p21 to enhance differentiated phenotypes. Cell Transplant. 11:(5):2002;421-428
60. Kobayashi N., Noguchi H., Fujiwara T., Tanaka N. Establishment of a reversibly immortalized human hepatocyte cell line by using Cre/loxP site-specific recombination. Transplant P. 32:(5):2000;1121-1122
61. Kobayashi N., Noguchi H., Watanabe T., Matsumura T., Totsugawa T., Fujiwara T., et al. Establishment of a tightly regulated human cell line for the development of hepatocyte transplantation. Hum Cell. 13:(1):2000;7-13
62. Lilja H., Arkadopoulos N., Blanc P., Eguchi S., Middleton Y., Meurling S., et al. Fetal rat hepatocytes: isolation, characterization, and transplantation in the Nagase analbuminemic rats. Transplantation. 64:(9):15 November 1997;1240-1248
63. Gruppuso P.A., Awad M., Bienieki T.C., Boylan J.M., Fernando S., Faris R.A. Modulation of mitogen-independent hepatocyte proliferation during the perinatal period in the rat. In Vitro Cell Dev Biol Anim. 33:(7):1997;562-568
64. Caperna T.J., Failla M.L., Kornegay E.T., Richards M.P., Steele N.C. Isolation and culture of parenchymal and non-parenchymal cells from neonatal swine liver. J Anim Sci. 61:(6):1985;1576-1586
65. Wege H., Le H.T., Chui M.S., Liu L., Wu J., Giri R., et al. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology. 124:(2):2003;432-444
66. Sussman N.L., Gislason G.T., Conlin C.A., Kelly J.H. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. 18:(5):1994;390-396
67. Spath G.F., Weiss M.C. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 140:(4):23 February 1998;935-946
68. Roberts E.A., Letarte M., Squire J., Yang S. Characterization of human hepatocyte lines derived from normal liver tissue. Hepatology. 19:(6):1994;1390-1399
69. Tosh D., Shen C.N., Slack J.M. Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology. 36:(3):2002;534-543
70. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 109:(10):2002;1291-1302
71. Zhao Y., Glesne D., Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA. 100:(5):4 March 2003;2426-2431
72. Gregory P.G., Connolly C.K., Toner M., Sullivan S.J. In vitro characterization of porcine hepatocyte function'. Cell Transplant. 9:(1):2000;1-10
73. Guguen-Guillouzo C., Guillouzo A. Modulation of functional activities in cultured rat hepatocytes. Mol Cell Biochem. 53-54:(1-2):1983;35-56
74. Mitaka T. The current status of primary hepatocyte culture. Int J Exp Pathol. 79:(6):1998;393-409
75. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science. 268:(5208):1995;233-239
76. Iredale J.P., Arthur M.J. Hepatocyte-matrix interactions. Gut. 35:(6):1994;729-732
77. Stamatoglou S.C., Hughes R.C. Cell adhesion molecules in liver function and pattern formation. FASEB J. 8:(6):4 January 1994;420-427
78. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and non-parenchymal cells. FASEB J. 13:(14):1999;1883-1900
79. Michalopoulos G.K., Bowen W., Zajac V.F., Beer S.D., Watkins S., Kostrubsky V., et al. Morphogenetic events in mixed cultures of rat hepatocytes and non-parenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology. 29:(1):1999;90-100
80. Mitaka T., Sato F., Mizuguchi T., Yokono T., Mochizuki Y. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic non-parenchymal cells. Hepatology. 29:(1):1999;111-125
81. Arenson D.M., Friedman S.L., Bissell D.M. Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology. 95:(2):1988;441-447
82. Loreal O., Levavasseur F., Fromaget C., Gros D., Guillouzo A., Clement B. Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am J Pathol. 143:(2):1993;538-544
83. Eicin Y.M., Dixit V., Gitnick G. Hepatocyte attachment on biodegradable modified chitosan membranes: in vitro evaluation for the development of liver organoids. Artif Organs. 22:(10):1998;837-846
84. Bissell D.M., Arenson D.M., Maher J.J., Roll F.J. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest. 79:(3):1987;801-812
85. Oda H., Nozawa K., Hitomi Y., Kakinuma A. Laminin-rich extracellular matrix maintains high level of hepatocyte nuclear factor 4 in rat hepatocyte culture. Biochem Biophys Res Commun. 212:(3):26 July 1995;800-805
86. Ponce M.L., Rojkind M. Rat hepatocytes attach to laminin present in liver biomatrix proteins by an Mg(++)-dependent mechanism. Hepatology. 22:(2):1995;620-628
87. Rojkind M., Gatmaitan Z., Mackensen S., Giambrone M.A., Ponce P., Reid L.M. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol. 87:(1):1980;255-263
88. Runge D., Runge D.M., Bowen W., Locker J., Michalopoulos G.K. Matrix induced re-differentiation of cultured rat hepatocytes and changes of CCAAT/enhancer binding proteins. Biol Chem. 378:(8):1997;873-881
89. Nagaki M., Shidoji Y., Yamada Y., Sugiyama A., Tanaka M., Akaike T., et al. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun. 210:(1):5 May 1995;38-43
90. Smalley M., Leiper K., Floyd D., Mobberley M., Ryder T., Selden C., et al. Behavior of a cell line derived from normal human hepatocytes on non-physiological and physiological-type substrates: evidence for enhancement of secretion of liver-specific proteins by a three-dimensional growth pattern. In Vitro Cell Dev Biol Anim. 35:(1):1999;22-32
91. Flendrig L.M., te Velde A.A., Chamuleau R.A. Semipermeable hollow fiber membranes in hepatocyte bioreactors: a prerequisite for a successful bioartificial liver? Artif Organs. 21:(11):1997;1177-1181
92. Flendrig L.M., la Soe J.W., Jorning G.G., Steenbeek A., Karlsen O.T., Bovee W.M., et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 26:(6):1997;1379-1392
93. Gerlach J., Kloppel K., Stoll P., Vienken J., Muller C. Gas supply across membranes in bioreactors for hepatocyte culture. Artif Organs. 14:(5):1990;328-333
94. Dixit V. Development of a bioartificial liver using isolated hepatocytes. Artif Organs. 18:(5):1994;371-384
95. Chen S.C., Mullon C., Kahaku E., Watanabe F., Hewitt W., Eguchi S., et al. Treatment of severe liver failure with a bioartificial liver. Ann NY Acad Sci. 831:31 December 1997;350-360
96. Demetriou A.A., Rozga J., Podesta L., Lepage E., Morsiani E., Moscioni A.D., et al. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol Suppl. 208:1995;111-117
97. Rozga J., Podesta L., Lepage E., Morsiani E., Moscioni A.D., Hoffman A., et al. A bioartificial liver to treat severe acute liver failure. Ann Surg. 219:(5):1994;538-544
98. Shatford R.A., Nyberg S.L., Meier S.J., White J.G., Payne W.D., Hu W.S., et al. Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res. 53:(6):1992;549-557
99. Sheil A.G., Sun J., Mears D.C., Waring M., Woodman K., Johnston B., et al. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model. Int J Artif Organs. 21:(1):1998;43-48
100. Ellis A.J., Hughes R.D., Wendon J.A., Dunne J., Langley P.G., Kelly J.H., et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 24:(6):1996;1446-1451
101. Nyberg S.L., Shatford R.A., Payne W.D., Hu W.S., Cerra F.B. Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology. 10:(3):1992;205-215
102. Gerlach J.C., Encke J., Hole O., Muller C., Ryan C.J., Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation. 58:(9):15 November 1994;984-988
103. Sauer I.M., Zeilinger K., Pless G., Kardassis D., Theruvath T., Pascher A., et al. Extracorporeal liver support based on primary human liver cells and albumin dialysis - treatment of a patient with primary graft non-function. J Hepatol. 39:(4):2003;649-653
104. Sauer I.M., Zeilinger K., Obermayer N., Pless G., Grunwald A., Pascher A., et al. Primary human liver cells as source for modular extracorporeal liver support - a preliminary report. Int J Artif Organs. 25:(10):2002;1001-1005
105. Flendrig L.M., la Soe J.W., Jörning G.G., Steenbeek A., Karlsen O.T., Bovée W.M., et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 26:(6):1997;1379-1392
106. Hughes R.D., Nicolaou N., Langley P.G., Ellis A.J., Wendon J.A., Williams R. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs. 22:(10):1998;854-858
107. Chen S.C., Hewitt W.R., Watanabe F.D., Eguchi S., Kahaku E., Middleton Y., et al. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs. 19:(11):1996;664-669
108. Amaout W.S., Moscioni A.D., Barbour R.L., Demetriou A.A. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res. 48:(4):1990;379-382
109. Flendrig L.M., Calise F., Di Florio E., Mancini A., Ceriello A., Santaniello W., et al. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs. 22:(10):1999;701-709
110. Cuervas-Mons V., Colas A., Rivera J.A., Prados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Transplantation. 69:(3):15 February 2000;337-344
111. Naka S., Takeshita K., Yamamoto T., Tani T., Kodama M. Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: an evaluation in the swine acute liver failure model. Artif Organs. 23:(9):1999;822-828
112. Alison M., Golding M., Lalani E.N., Nagy P., Thorgeirsson S., Sarraf C. Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. J Hepatol. 26:(2):1997;343-352
113. Theise N.D., Saxena R., Portmann B.C., Thung S.N., Yee H., Chiriboga L., et al. The canals of Hering and hepatic stem cells in humans. Hepatology. 30:(6):1999;1425-1433